An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer

NCT00051779 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms
Breast Cancer
Metastasis

Interventions

DRUG: CAL

Sponsor

Chugai Pharma USA